Latest AI and machine learning research in skin cancer for healthcare professionals.
OBJECTIVE: Automated literature screening in biomedical research is often hindered by domain shifts and scarcity of labeled data, which limit model accuracy and generalizability. While large language models (LLMs) perform well in zero-shot settings, they often fail to capture complex, domain-specific reasoning patterns. To address this limitation, this study investigates whether an interactive, we...
The efficacy of PD-1 inhibitor pucotenlimab (HX008) in solid tumors exhibits heterogeneity. This study integrated data from 6 clinical trials (covering gastric/gastroesophageal junction cancer, triple-negative breast cancer, melanoma, and dMMR/MSI-H solid tumors) using Bayesian meta-analysis, machine learning (optimal XGBoost AUC = 0.86), and network meta-analysis to construct an integrated "effic...
BACKGROUND: Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence larg...
PURPOSE: Circulating tumor fraction estimate (ctFE) is a machine learning-derived composite metric of circulating tumor DNA (ctDNA) burden. We hypothe...
The poor prognosis of lung adenocarcinoma (LUAD) remains unimproved. This study aimed to identify lymph node metastasis (LNM)-related and cellular imm...
Clear cell renal cell carcinoma (ccRCC) is distinguished by the absence of definitive diagnostic markers and efficacious treatment modalities, factors...
OBJECTIVE: Microsatellite instability (MSI) has emerged as a key predictive biomarker for chemotherapy and immunotherapy response, and as a prognostic...
This study developed a risk score model using PANoptosis and immune-related genes to predict glioblastoma (GBM) prognosis. Utilizing TCGA data and 66 ...
BACKGROUND: Glioblastoma (GBM) is one of the most aggressive brain tumors with a poor prognosis despite current treatment modalities. This study aimed...
Ovarian cancer (OC) remains therapeutic challenge due to its complex molecular heterogeneity and therapy-induced adaptive resistance. While non-apopto...
Despite the rational therapeutic premise of microRNA (miRNA) replacement or inhibition for cancer treatment, its clinical translation remains signific...
BACKGROUND: Glioblastoma (GBM) exhibits profound cellular heterogeneity and a highly immunosuppressive microenvironment in which tumor-associated macr...
Recent advances in T cell-based immunotherapies highlight the urgent need for precise and dynamic monitoring across the entire cell culture pipeline. ...
Targeting programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) with immune checkpoint inhibitors (ICIs) has...
BACKGROUND AND OBJECTIVE: Characterizing the tumor microenvironment (TME) requires integrating multiple physiological features, including oxygenation,...
OBJECTIVE: To benchmark the pathogenicity predictions of AlphaMissense, a deep learning model, against high-throughput functional scores from saturati...
Radiotherapy (RT) remains a cornerstone of cancer management but is fundamentally constrained by normal tissue toxicity, intrinsic and acquired radior...
Programmed cell death (PCD) and cellular immunity play pivotal roles in colorectal cancer (CRC) progression; understanding their crosstalk and identif...
Immunotherapy has revolutionized hepatocellular carcinoma (HCC) management, necessitating personalized strategies in current guidelines. Despite curat...